| abstract |
The present invention preferably provides controlled release of the contained pharmaceutically active compound (A), very preferably tamper resistant, most preferably extending with a breaking strength (B 1 ) of 500 N or more in the extending direction (E 1 ). It relates to a pharmaceutical dosage form having a breaking strength (B 2 ) of less than 500N in the direction (E 2 ). |